 |
인쇄하기
취소
|
First Botox generic to be marketed by Meditox.
Meditox, a Korean bio venture company, has obtained the KFDA approval for the sale of "botulism injection", a generic of Botox, through their own technical development.
The development of an injectable botulism by Meditox would be the 4th in the world, first in Korea, the company said.
The product will be sold at the first half of this year at an earliest through Pacific Pharm.
The development of an injectable botulism by Meditox would be the 4th in the world, first in Korea, the company said.
The product will be sold at the first half of this year at an earliest through Pacific Pharm.
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.